Tue 01/18/2022 10:40 AM
Share this article:
German specialist ceramics producer CeramTec, a well-known issuer with a long-term track record of growing earnings and margins, benefits from a dominant leadership position in the hip replacement market and solid growth prospects in the dental segment, investors told Reorg. They added that its industrial segment is more cyclical but well diversified. Investors commented that the proposed pricing of the group’s €1.43 billion term loan looks tight given the deal’s plus 7x total net leverage...
Share this article:
This article is an example of the content you may receive if you subscribe to a product of Reorg Research, Inc. or one of its affiliates (collectively, “Reorg”). The information contained herein should not be construed as legal, investment, accounting or other professional services advice on any subject. Reorg, its affiliates, officers, directors, partners and employees expressly disclaim all liability in respect to actions taken or not taken based on any or all the contents of this publication. Copyright © 2024 Reorg Research, Inc. All rights reserved.
Thank you for signing up
for Reorg on the Record!